Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes
Get Live Data
1.275    0.025 (2.04%)
Bid:
1.20
Ask:
1.35
Spread: 0.15 (12.50%)
Market Cap: £20.07m
GDR Live PriceLast checked at - London Stock Exchange

Intraday Genedrive Share Chart

Additional Listing

23 Apr 2014 08:45

RNS Number : 3069F
Epistem Holdings plc
23 April 2014
 



Epistem Holdings Plc

Additional Listing

Epistem (AIM: EHP) announces that 12,000 new ordinary shares of 1.5 pence each (the "New Ordinary Shares") have been issued and allotted pursuant to the exercise of options under the Epistem Holdings Plc EMI Share Option Scheme.

Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM. Admission is expected to be effective on 29th April, 2014 and, when issued, the New Ordinary Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Following the admission to trading of the New Ordinary Shares, Epistem will have 9,765,240 ordinary shares of 1.5 pence each in issue.

 

 

For further details please contact:

 

Epistem Plc

Matthew Walls, CEO +44 161 606 7258

John Rylands, Finance Director +44 161 606 7244

 

Peel Hunt LLP

James Steel +44 20 7418 8900

Clare Terlouw

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISPGUWCCUPCUMW
Date   Source Headline
21st Jul 202011:05 amRNSSecond Price Monitoring Extn
21st Jul 202011:00 amRNSPrice Monitoring Extension
16th Jul 20204:29 pmRNSHolding(s) in Company
13th Jul 20209:00 amRNSPrice Monitoring Extension
10th Jul 20202:05 pmRNSSecond Price Monitoring Extn
10th Jul 20202:00 pmRNSPrice Monitoring Extension
10th Jul 20207:01 amRNSNew Genedrive® 96 Exporter software
10th Jul 20207:00 amRNSTrading update
1st Jul 20207:00 amRNSTotal Voting Rights
26th Jun 20203:24 pmRNSHolding(s) in Company
25th Jun 20203:39 pmRNSHolding(s) in Company
22nd Jun 20203:06 pmRNSHolding(s) in Company
22nd Jun 202011:08 amRNSHolding(s) in Company
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
17th Jun 20204:41 pmRNSSecond Price Monitoring Extn
17th Jun 20204:35 pmRNSPrice Monitoring Extension
17th Jun 20202:05 pmRNSSecond Price Monitoring Extn
17th Jun 20202:00 pmRNSPrice Monitoring Extension
16th Jun 202011:37 amRNSConversion of Convertible Bond
15th Jun 20204:40 pmRNSSecond Price Monitoring Extn
15th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20207:00 amRNSInvestor presentation
9th Jun 20204:41 pmRNSSecond Price Monitoring Extn
9th Jun 20204:36 pmRNSPrice Monitoring Extension
9th Jun 20202:06 pmRNSSecond Price Monitoring Extn
9th Jun 20202:00 pmRNSPrice Monitoring Extension
9th Jun 202011:05 amRNSSecond Price Monitoring Extn
9th Jun 202011:00 amRNSPrice Monitoring Extension
29th May 20203:02 pmRNSHolding(s) in Company
29th May 202012:19 pmRNSHolding(s) in Company
29th May 202011:49 amRNSHolding(s) in Company
29th May 20208:30 amRNSHolding(s) in Company
28th May 20202:06 pmRNSSecond Price Monitoring Extn
28th May 20202:01 pmRNSPrice Monitoring Extension
28th May 20201:18 pmRNSApplication for Block Listing
28th May 202012:50 pmRNSHolding(s) in Company
28th May 202011:05 amRNSSecond Price Monitoring Extn
28th May 202011:00 amRNSPrice Monitoring Extension
27th May 202011:35 amRNSResult of General Meeting
27th May 20208:15 amRNSHolding(s) in Company
26th May 202011:58 amRNSHolding(s) in Company
26th May 20209:30 amRNSHolding(s) in Company
22nd May 202011:05 amRNSSecond Price Monitoring Extn
22nd May 202011:00 amRNSPrice Monitoring Extension
22nd May 20209:05 amRNSSecond Price Monitoring Extn
22nd May 20209:00 amRNSPrice Monitoring Extension
22nd May 20207:00 amRNSGenedrive 96 SARS-CoV-2 Kit receives CE-IVD Mark
21st May 20209:36 amRNSHolding(s) in Company
20th May 20203:38 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.